Munafa Stock Market Course + Intraday & FNO calls 
Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Halozyme Therapeutics (HALO)
Technical Analysis Report for USA stock HALO Halozyme Therapeutics. Dated: 20 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics then click here. or read Experts views on Halozyme Therapeutics or Forecast & share price targets of Halozyme Therapeutics
Halozyme Therapeutics Opened at 78.52 and Closed at: 77.09, which is -0.93% of previous session's close. It moved within a range of 77.01 and 79.04
The session was a Bearish session with an average volume of 1552600, which is 4.52% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 76.04 and resistance for tomorrow is 78.07
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 76.39, 75.68 resistance for tomorrow's hourly charts is 78.42, 79.74
10 Day SMA for Halozyme Therapeutics (HALO) is 77.62 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Halozyme Therapeutics (HALO) is 76.31 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Halozyme Therapeutics (HALO) is 71.83 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 68.89 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Halozyme Therapeutics is 69.3 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Halozyme Therapeutics is at 76.31 and 200 DMA is at 69.3, while 50 DMA and 100 DMA are at 71.83 and 68.89 respectively
Halozyme Therapeutics (HALO) moving average of 20 SMA is at 76.31 and 20 EMA is at 75.98
| Date | Closing Price | 20 SMA | 20 EMA |
| 20 Mon Jul | 77.09 | 76.31 | 75.98 |
| 17 Fri Jul | 77.81 | 75.89 | 75.86 |
| 16 Thu Jul | 77.54 | 75.42 | 75.65 |
| 15 Wed Jul | 75.82 | 75.03 | 75.45 |
| 14 Tue Jul | 75.05 | 74.8 | 75.41 |
| 13 Mon Jul | 76.11 | 74.52 | 75.45 |
Halozyme Therapeutics (HALO) moving average of 50 SMA is at 71.83 and 50 EMA is at 72.96
| Date | Closing Price | 50 SMA | 50 EMA |
| 20 Mon Jul | 77.09 | 71.83 | 72.96 |
| 17 Fri Jul | 77.81 | 71.62 | 72.79 |
| 16 Thu Jul | 77.54 | 71.39 | 72.58 |
| 15 Wed Jul | 75.82 | 71.16 | 72.38 |
| 14 Tue Jul | 75.05 | 70.93 | 72.24 |
| 13 Mon Jul | 76.11 | 70.71 | 72.13 |
Halozyme Therapeutics (HALO) moving average of 100 SMA is at 68.89 and 100 EMA is at 70.98
| Date | Closing Price | 100 SMA | 100 EMA |
| 20 Mon Jul | 77.09 | 68.89 | 70.98 |
| 17 Fri Jul | 77.81 | 68.82 | 70.86 |
| 16 Thu Jul | 77.54 | 68.75 | 70.72 |
| 15 Wed Jul | 75.82 | 68.7 | 70.58 |
| 14 Tue Jul | 75.05 | 68.67 | 70.47 |
| 13 Mon Jul | 76.11 | 68.73 | 70.38 |
Halozyme Therapeutics (HALO) moving average of 200 SMA is at 69.3 and 200 EMA is at 68.77
| Date | Closing Price | 200 SMA | 200 EMA |
| 20 Mon Jul | 77.09 | 69.3 | 68.77 |
| 17 Fri Jul | 77.81 | 69.28 | 68.69 |
| 16 Thu Jul | 77.54 | 69.26 | 68.6 |
| 15 Wed Jul | 75.82 | 69.24 | 68.51 |
| 14 Tue Jul | 75.05 | 69.23 | 68.44 |
| 13 Mon Jul | 76.11 | 69.23 | 68.37 |
Halozyme Therapeutics has performed better than Arcus Biosciences in short term. Holding Halozyme Therapeutics could be a better choice for now!
Baxter International has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Baxter International, about 0.52% more returns!
Halozyme Therapeutics has performed better than Voyager Therapeutics in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Vanda Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Nucana Plc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Lipocine Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Livanova Plc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Ligand Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Ligand Pharmaceuticals, about 0.4% more returns!
Halozyme Therapeutics has performed better than Ironwood Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Idexx Laboratories in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Healthcare Services in short term. Holding Halozyme Therapeutics could be a better choice for now!
Genesis Healthcare has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Genesis Healthcare, about 4.17% more returns!
Halozyme Therapeutics has performed better than Exelixis Inc in short term. Holding Halozyme Therapeutics could be a better choice for now!
Eton Pharmaceuticals has performed better than Halozyme Therapeutics in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 13.78% more returns!
Halozyme Therapeutics has performed better than Anavex Life in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Amarin Corporation in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics has performed better than Adial Pharmaceuticals in short term. Holding Halozyme Therapeutics could be a better choice for now!
Halozyme Therapeutics Technical analysis of indicators
Price action analysis of Halozyme Therapeutics (HALO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term but the sell signal is initial and weak.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Halozyme Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 77.74 and Halozyme Therapeutics HALO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Halozyme Therapeutics HALO stock. Volume based technical analysis of Halozyme Therapeutics HALO stock is negative.
Halozyme Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock HALO Halozyme Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And HALO Experts View which covers a lot of information including buying and selling signals
HALO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Halozyme Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Halozyme Therapeutics (HALO) Technical (Analysis) Reports Halozyme Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
